SBIR/STTR Research Award

Development of 3D Rat Nerve-on-a-Chip Model for Chemical Toxicity Screening

Award identifier 96733eb172c80f0204a11d55e7bddcb5a6565e59f8b74137483e66d5bc264dd6Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$197,625

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
28bio, Inc.
Proposal award date
2018-09-24
Contract end date
2019-08-31
UEI
RT13MNMRHL33
Solicitation number
ES17-008
Topic code
NIEHS

Research abstract

Abstract Development ofD organotypic cellular models utilizing animal cells is important for the validation of these systems by direct comparison to animal dataA few organizations have been successful in providing such assays for various organ systemsHoweverdevelopment of peripheral nerve assays is laggingCommonly used peripheral neural culture preparations are not predictive of clinical toxicitypartially since they typically utilize apoptosis or neurite elongation as measurable endpointswhereas adult peripheral neurons are fully grown and known to resist apoptosisNerve conduction testing and histomorphometry of biopsies are the most clinicallyrelevant measures of neuropathyNeverthelessno culture models that provide such metrics currently existVarious brain culture systemssuch asD neural constructscerebral organoids or neurospheres to assess neurotoxicity were developedHowevernone recapitulated the biomimetic complexity of the nervous system especially peripheral nervous systemD neural toxicity assays that seek to recapitulate the most relevant anatomic and physiological toxic pathology in a simple model require a stronger focus on system architectureWe have developed an innovative sensory nerve on a chip model by culturing dorsal root ganglia in micropatterned hydrogel constructs to constrain axon growth in aD arrangement analogous to peripheral nerve anatomyFurtherelectrically evoked population field potentials resulting from compound action potentialsCAPsmay be recorded reproducibly in these model systemsThese early results demonstrate the feasibility of using microengineered neural tissues that are amenable to morphological and physiological measurements analogous to those of animaland clinicaltestsFrom a single in vitro preparationwe can measure CAP amplitude and conduction velocityand then subsequently section the tissue to measure histomorphological parameters such as axon diameteraxon densityand myelinationWe hypothesize that thisD organotypic system is capable of detecting neural toxicity parameters in ways that mimic clinical neuropathologyThis versatile system could also further be used for performingomicsstudies and thus will eventually be used for determining a large spectrum of toxicological parameters resulting in understanding mechanisms of action as well as improved understanding of biological processesThe objective of this project is to demonstrate that certain chemical toxins known for causing neurotoxicity in rats will induce toxicity in microengineered neural tissue that can be quantified using morphological and physiological measures analogous to clinical metricsWe will approach this objective by first enhancing the throughput of our system by engineeringD microelectrodes for testing electrophysiological characteristics of the model systemNextwe will determine the baseline variability and characterize structure function relationships using theD microelectrodesWe will then quantify changes induced by acute application of specific chemical toxins in order to demonstrate the technical merit of using the compound action potentialcAPwaveform as a preclinical assay of neurotoxicity Narrative While animal neural toxicity testing provides more specific anatomical and physiological parameters after chemical exposurethe cost and time of performing such experiments precludes their use for screening thousands of compoundsWe have developed an innovative sensory nerve on a chip model of cultured rat dorsal root ganglia in aD arrangement analogous to peripheral nerve anatomy that can record compound action potential amplitude and conduction velocity as well as measure histomorphological parameters such as axon diameteraxon densityand myelinationIf successfulthe assay would be used as an animal neural toxicity screening assayscreening candidate compounds for neural toxicitypredicting compound in vivo toxicity profileThussignificantly obviating costly and cumbersome animal studies currently required for drug development

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2016–2022). Reported award amounts total $3,257,984. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.